MGO One Seven’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,567
| Closed | -$462K | – | 869 |
|
|
2023
Q1 | $462K | Sell |
4,567
-543
| -11% | -$55K | 0.03% | 502 |
|
|
2022
Q4 | $610K | Sell |
5,110
-2,270
| -31% | -$271K | 0.06% | 335 |
|
|
2022
Q3 | $783 | Sell |
7,380
-285
| -4% | -$30 | 0.03% | 289 |
|
|
2022
Q2 | $747K | Sell |
7,665
-177
| -2% | -$17.3K | 0.1% | 227 |
|
|
2022
Q1 | $735K | Buy |
7,842
+4,339
| +124% | +$407K | 0.08% | 275 |
|
|
2021
Q4 | $298K | Sell |
3,503
-493
| -12% | -$41.9K | 0.03% | 496 |
|
|
2021
Q3 | $421K | Sell |
3,996
-117
| -3% | -$12.3K | 0.05% | 372 |
|
|
2021
Q2 | $400K | Buy |
4,113
+2
| +0% | +$195 | 0.06% | 392 |
|
|
2021
Q1 | $399K | Buy |
4,111
+305
| +8% | +$29.6K | 0.07% | 353 |
|
|
2020
Q4 | $365K | Sell |
3,806
-348
| -8% | -$33.4K | 0.08% | 329 |
|
|
2020
Q3 | $399K | Buy |
+4,154
| New | +$399K | 0.09% | 283 |
|
|
2019
Q1 | – | Sell |
-210
| Closed | -$14K | – | 1189 |
|
|
2018
Q4 | $14K | Buy |
+210
| New | +$14K | 0.01% | 1032 |
|
|
2018
Q1 | $5K | Buy |
65
+3
| +5% | +$231 | ﹤0.01% | 1317 |
|
|
2017
Q4 | $5K | Buy |
+62
| New | +$5K | ﹤0.01% | 1306 |
|